PharmAust (ASX:PAA) Short-Term Debt : A$0.00 Mil (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is PharmAust Short-Term Debt?

PharmAust's Short-Term Debt for the quarter that ended in Dec. 2023 was A$0.00 Mil.

PharmAust's quarterly Short-Term Debt declined from Dec. 2022 (A$0.14 Mil) to Jun. 2023 (A$0.00 Mil) but then stayed the same from Jun. 2023 (A$0.00 Mil) to Dec. 2023 (A$0.00 Mil).

PharmAust's annual Short-Term Debt increased from Jun. 2021 (A$0.04 Mil) to Jun. 2022 (A$0.21 Mil) but then declined from Jun. 2022 (A$0.21 Mil) to Jun. 2023 (A$0.00 Mil).

PharmAust Short-Term Debt Historical Data

The historical data trend for PharmAust's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmAust Short-Term Debt Chart

PharmAust Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Short-Term Debt

Get a 7-Day Free Trial

0.14

0.18

0.04

0.21

PharmAust Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Short-Term Debt	Get a 7-Day Free Trial															0.15	0.21	0.14	-	-

PharmAust Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

PharmAust Short-Term Debt Related Terms

Thank you for viewing the detailed overview of PharmAust's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmAust (ASX:PAA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmAust Ltd (ASX:PAA) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

ECQ:Germany ECQ:Germany

Address

1 Kyle Way, Suite 116, Claremont, Perth, WA, AUS, 6010

Website

https://www.pharmaust.com

PharmAust Ltd operates as a drug discovery and development company in Australia, Switzerland, and internationally. It develops drug discovery intellectual property for the treatment of various cancers in humans and animals. The company offers Monepantel and Albendazole, which are in Phase II clinical trials for the treatment of cancer. It also provides medicinal and synthetic chemistry services on a contract basis to the drug discovery and pharmaceutical industries.